missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human IFN beta Synthetic Peptide
Click to view available options
Quantity:
50 μg
Unit Size:
50µg
Description
IFN-beta Synthetic Peptide, PEP-0507, from Invitrogen.
Type I Interferons (IFN-alpha/beta) are produced primarily in response to viral infection by Natural IFN-producing cells (IPCs) as part of the host immune response. IFNs can also inhibit the development of tumors. IFN-beta binding results in the activation of the tyrosine kinases Jak1 and Tyk2, phosphorylation of members of the STAT family of transcription factors, and the transcription and expression of the immune response genes. More recently, several members of the toll-like receptor (TLR) family were found to stimulate the production IFN-beta. IFN-beta is currently used clinically for treatment of tumors, infections and multiple sclerosis.
Specifications
Specifications
| Gene ID (Entrez) | 3456 |
| Species | Human |
| Purification Method | purified |
| Accession Number | P01574 |
| Common Name | Human IFN beta |
| Concentration | 1 mg/mL |
| Content And Storage | -20°C |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formulation | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction